2ⁿᵈ Edition of the Cancer R&D World Conference 2026
Speakers - CRDWC 2026
Ilya Tsimafeyeu
Ilya Tsimafeyeu
- Designation: BUCARE
- Country: USA
Biography
Dr. Ilya Tsimafeyeu is a medical oncologist and researcher specializing in preclinical and clinical drug development. He is the director and founder of the Bureau for Cancer Research - BUCARE, formerly known as the Kidney Cancer Research Bureau. Over the past decade, BUCARE has led numerous clinical and translational trials, contributing valuable insights into the role of fibroblast growth factor (FGF) and its receptors in the development of various cancers. These early findings have supported the development of new therapies by companies such as Eisai and OncoMax. Dr. Tsimafeyeu pioneered the discovery of a first-in-class allosteric FGFR2 inhibitor (alofanib, currently in Phase 1b trials) and an anti-FGFR1 humanized antibody (OM-RCA-01, currently in Phase 1b/2 clinical trial).
Dr. Tsimafeyeu is also a faculty member of the College of the European School of Oncology (ESCO, Italy) and serves on the IESG group of the American Society of Clinical Oncology (ASCO, USA). He has received several prestigious awards, including the IDEA ASCO Award, ASCO Merit Award, AACR-AstraZeneca Award, First Prize at the EMUC conference, and the Gold Ribbon for Late-Breaking Abstract at ENDO, among others.
We, the Precision Global Conferences, welcome all the students, scholars, researchers, and delegates across the globe to patronize their presence at the& ...
Read More>>
Organizer
